Does helical tomotherapy-based intraperitoneal radiotherapy improve tumor response and control in a patient with metastatic peritoneal myxoid liposarcoma?
Helical tomotherapy-based intraperitoneal radiotherapy may be a feasible and effective salvage treatment for metastatic peritoneal myxoid liposarcoma.
This case suggests that low fraction-sized intraperitoneal radiotherapy (1.6 Gy administered once daily), followed by a focal boost using helical tomotherapy, is a feasible treatment without side effects. It produced an excellent tumor response, and durable intraperitoneal control for metastatic peritoneal myxoid liposarcoma.
Choi et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: